New Pricing System Could Deal A Blow To South Korea's Generic-Dependent Companies
This article was originally published in PharmAsia News
Executive Summary
SEOUL - As part of its effort to root out illegal rebates, the Ministry for Health, Welfare and Family Affairs said it would launch a new "drug-pricing system" in October aimed at compensating hospitals that buy drugs at lower prices than their government-set maximum prices
You may also be interested in...
Effects Of Korea's New Drug-Pricing System Still Murky
Local companies and multinational corporations will engage in "bloody battles" to offer the lowest bidding prices to the large nationwide hospitals, one analyst predicts.
Effects Of Korea's New Drug-Pricing System Still Murky
Local companies and multinational corporations will engage in "bloody battles" to offer the lowest bidding prices to the large nationwide hospitals, one analyst predicts.
Effects Of Korea's New Drug-Pricing System Still Murky
SEOUL - Nearly a year after the South Korean Health Ministry announced new policies aimed at eradicating bribery and promoting more transparent drug pricing, effects of a new drug-pricing system remain unclear, industry watchers say